SCHEMBL3792331

SCHEMBL3792331

Cc1cc(Oc2ccc(N)c(F)c2)c2cc(F)ccc2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ CASP1 P29466 1/20 0.44
▸ CASP7 P55210 1/20 0.44
▸ CHRM4 P08173 1/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ GPR35 Q9HC97 1/20 0.39
▸ ACHE P22303 4/20 0.38
▸ BCHE P06276 3/20 0.38
▸ DHODH Q02127 2/20 0.38
▸ NCF1 P14598 1/20 0.38
▸ GCK P35557 2/20 0.38
▸ NQO2 P16083 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ BRAF P15056 1/20 0.37
▸ MAPK14 Q16539 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ UBE2N P61088 1/20 0.37
▸ TLR9 Q9NR96 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3794932 0.88 CHRM4 (0.44) ALDH1A1HSD17B10CASP1CASP7CHRM4
SCHEMBL3792329 0.83 KDM4E (0.43) ALDH1A1HSD17B10DHODHKDM4EBRAF
SCHEMBL3794930 0.80 PARP10 (0.50) ALDH1A1HSD17B10KMT2ADHODHNQO2
SCHEMBL27890180 0.78 ALDH1A1 (0.62) ALDH1A1HSD17B10CASP1CASP7KMT2A
SCHEMBL1591628 0.75 AXL (0.50) KMT2ABRAFMAPK14
SCHEMBL1591382 0.75 AXL (0.44) CHRM4
SCHEMBL439684 0.75 NCF1 (0.59) ALDH1A1HSD17B10CASP1CASP7KMT2A
SCHEMBL2187666 0.73 TGFBR1 (0.41) ALDH1A1GCK
SCHEMBL1592197 0.73 RORC (0.51) ALDH1A1KMT2AMEN1BRAF
SCHEMBL29394218 0.73 ALDH1A1 (0.58) ALDH1A1KMT2AMEN1GCKKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206130-B2 Quinoline derivatives as AXL kinase inhibitors MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2015-12-08 — — US claimed
EP-2262772-A1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2010-12-22 — — EP claimed
WO-2009127417-A1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2009-10-22 — — WO claimed
US-9206130-B2 Quinoline derivatives as AXL kinase inhibitors MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2015-12-08 — — US disclosed
EP-2262772-B1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS MAX PLANCK GESELLSCHAFT (DE) 2012-07-18 — — EP disclosed
EP-2262772-A1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2010-12-22 — — EP disclosed
WO-2009127417-A1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2009-10-22 — — WO disclosed
Send feedback